期刊文献+

急性冠状动脉综合征患者血浆氧化脂蛋白(a)水平 被引量:6

Plasma oxidized lipoprotein(a) levels in patients with acute coronary artery disease
下载PDF
导出
摘要 目的探讨急性冠状动脉综合征(ACS)患者血浆氧化脂蛋白(a)[ox-Lp(a)]水平的变化及机制。方法分别检测96例ACS、89例非ACS患者和100例健康人血浆ox-Lp(a)水平,冠状动脉造影确认冠状动脉病变程度。结果ACS组和非ACS组ox-Lp(a)水平均高于对照组,且ACS组ox-Lp(a)水平显著高于非ACS组。ACS组ox-Lp(a)/Lp(a)比值高于非ACS组和健康对照组,后两者中该比值无显著差别。ACS患者中ox-Lp(a)水平与冠状动脉病变程度相关(r=0.370,P=0.000),非ACS组中两者不相关(r=0.051,P=0.634)。多因素分析显示,ox-Lp(a)、TG水平及年龄解释ACS患者15.1%的病变程度。结论高ox-Lp(a)水平与ACS的发生、病变程度有关,有益于鉴别ACS。 Objective To investigate the association of increased oxidized lipoprotein(a) [ ox-Lp(a) ] levels with the severity of acute coronary syndromes (ACS) and relevant possible mechanisms. Methods Ox-Lp (a) levels were measured in 96 ACS patients, 89 non-ACS patients, and 100 healthy subjects. The extent of coronary artery disease (CAD) was determined by coronary angiography. Results Ox-Lp(a) levels significantly increased in ACS or non-ACS patients, compared with those in control. ACS patients had higher ox-Lp(a) levels than non-ACS patients. The ratio of ox-Lp(a) to Lp(a) in ACS was higher than that in either non-ACS or control, whereas the ratio was comparable between the non-ACS and control. Ox-Lp (a) levels were found to be associated with a graded increase with the severity of CAD in the ACS ( r = 0. 370, P =0. 001 ), yet not in the non-ACS ( r = 0.051, P = 0.634). Multiple linear regression analysis showed that ox-Lp( a), triglyceride, and age accounted for 15.1% of the variation in the severity of CAD in ACS patients. Conclusions Elevated ox-Lp(a) levels are associated with the presence and severity of ACS, and testing ox-Lp (a) may be useful in identifying ACS patients.
出处 《临床检验杂志》 CAS CSCD 北大核心 2010年第1期24-26,共3页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金资助项目(30872411和30471649)
关键词 脂蛋白 氧化 动脉粥样硬化 急性冠状动脉综合征 冠心病 lipoproteins oxidation atherosclerosis acute coronary syndrome coronary artery disease
  • 相关文献

参考文献14

  • 1汪俊军,顾振华,张春妮,范乐明.脂蛋白(a)氧化和自身免疫与动脉粥样硬化的关系[J].医学研究生学报,2005,18(8):740-742. 被引量:22
  • 2Wang JJ, Niu DM, Meng Y, et al. Plasma oxidized lipoprotein(a) and its immune complexes are present in newborns and children[J]. Clin Chim Acta, 2009, 4071(1-2): 1-5. 被引量:1
  • 3Wang JJ, Zhang CN, Meng Y, et el. Elevated levels of oxidized lipnprotein (a) are associated with the presence and severity of acute coronavy syndromes[J].Clin Chim Acre, 2009 ,407 (1-2) :79-82. 被引量:1
  • 4Wang J J, ttu B, Kong LT, et al. Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: Plasma concentrations and relationship to inflammation[ J ]. Clin Chim Acta, 2008, 390( 1-2): 67-71. 被引量:1
  • 5Wang JJ, Zhang CN, Gong JB, et al. Development of new enzymelinked immunosorbent assay for oxidized lipoprotein (a) by using puri- fied human oxidized lipoprotein(a) autoantibodies as capture antibody [J]. Clin Chim Acta, 2007,385(1-2) : 73-78. 被引量:1
  • 6Wang J J, Zhuang YY, Yao XD. Quantitation of plasminogen epitopes of seram lipoprotein(a) by sandwich enzyme linked immunosorbent assay[J]. Clin Chim Acta, 1997, 265(1): 121-130. 被引量:1
  • 7Yamada S, Morishita R, Nakamura S, et al. Development of antibody against epitope of lipoprotein(a) modified by oxidation: evaluation of new enzyme-linked immunosorbent assay for oxidized lipoprotein (a) [J]. Circulation, 2000, 102(14) : 1639-1644. 被引量:1
  • 8Podrez EA, O'Neil J, Salomon RG, et al. Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA[ J ]. Kidney Int, 1998, 54(2) : 637-645. 被引量:1
  • 9孟扬,汪俊军,韩爱忠,张春妮.急性、非急性冠状动脉病变患者血浆氧化低密度脂蛋白的变化[J].临床检验杂志,2009,27(1):44-46. 被引量:3
  • 10Edelstein C, Ptaffinger D, Hinman J, et al. Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential proinflammatory properties to human apolipoprotein (a) [J].J Biol Chem, 2003,278(52) : 52841-52847. 被引量:1

二级参考文献9

共引文献23

同被引文献67

  • 1谭小进,王岳林.冠心病患者心电图ST段水平延长与冠状动脉狭窄程度的相关性及诊断价值[J].中国动脉硬化杂志,2004,12(6):710-712. 被引量:12
  • 2汪俊军,顾振华,张春妮,范乐明.脂蛋白(a)氧化和自身免疫与动脉粥样硬化的关系[J].医学研究生学报,2005,18(8):740-742. 被引量:22
  • 3Cesur M, Ozbalkan Z, Temel MA, et al. Ethnieity may be a reason for lipid changes and hing Lp(a) levels in rheumatoid arthritis. Clin Rheumato1,2007,26 ( 3 ) : 355 361. 被引量:1
  • 4Peynet J, Beaudeux JL,Woimant F, et al. Apolipoprotein(a) size polymorphism in young adults with ischemic stroke. Atherosclerosis, 1999,142 ( 1 ) :233 239. 被引量:1
  • 5Kaplan MJ. Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol, 2006,18 ( 3 ) 289 297. 被引量:1
  • 6Van Hahn VP, Nielen MM, Nurmohamed MT, et al. Lipids and inflammation Serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis,2007,66(2) : 184 188. 被引量:1
  • 7Diaz Peromingo JA, Carbajal DG, Alban Salgado A. Lipoprotein(a) in patients on hemodialysis. Acta Med Austriaca, 2004,31 (3) :73 -75. 被引量:1
  • 8BENNET A, DI ANGELANTONIO E, ERQOU S, et al. Lipoprotein(a) levels and risk of future coro nary heart disease large-scale prospective data[J].Arch Intern Med, 2008,168 : 598- 608. 被引量:1
  • 9ERQOU S, KAPTOGE S, PERRY P L, et al. Lipo- protein (a) concentration and the risk Of coronary heart disease, stroke, and nonvascular mortality[J]. JAMA, 2009,302 : 412 - 423. 被引量:1
  • 10LAMON-FAVA S, MARCOV1NA S M, ALBERS J J, et al. Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study[J]. J Lipid Res, 2011,52: 1181- 1187. 被引量:1

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部